W10-1911 previous work on BNER for disease mention recognition . Then , Section 3 describes
W10-1911 not enough work done on disease mention recognition . Difficulty of obtaining adequate
W07-1000 , the number of papers on gene mention recognition was quite small . We did see
P12-1089 results evaluated on the named mention recognition task are superior overall , giving
W10-1911 specifically tailored for disease mention recognition . The system1 outperforms other
S10-1001 might be a direct effect of the mention recognition task . Mention recognition in
W10-1902 performing systems in the Gene Mention Recognition task of BioCreAtIvE II ( Smith
W10-1911 mostly focused on gene/protein mention recognition . Machine learning ( ML ) based
W10-1902 used in the BioCreAtIvE II Gene Mention Recognition task in 2006 . It was built from
W10-1911 based approaches for gene/protein mention recognition have already achieved a sufficient
S15-2067 coupling sequence la - belling for mention recognition with an STS measure for concept
W10-1911 specifically for benchmarking of disease mention recognition systems . An improved version
S10-1001 the mention recognition task . Mention recognition in the regular setting falls
E14-1052 ACE 2005 , but it seems that its mention recognition is not designed for ACE 2005
W10-1911 BNER is focused on gene/protein mention recognition . State-of-the-art BNER systems
W10-1911 feature set tailored for disease mention recognition and outperforms the state-ofthe-art
W10-1902 and Pereira , 2005 ) . The Gene Mention Recognition task was included in both BioCreAtIvE
W10-1911 the well studied gene/protein mention recognition task is not necessarily equally
W10-1911 scope rules . <title> Disease Mention Recognition with Specific Features </title>
W10-1911 of the art on ML based disease mention recognition in biomedical literature ( Leaman
hide detail